Accessibility Menu
908 Devices logo

908 Devices(NASDAQ) MASS

Market Cap$328.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-84%
5 Year-74%
1 Year+22%
1 Month-10%
$7.98
+4.45%
+0.34Today
After hours$8.01+$0.02 (+0.31%)
908 Devices last closing stock price
MetricPriceDate
Last closeUSD 8.012026-07-31
908 Devices stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+12.18%USD 7.142026-07-24
1 month-9.8%USD 8.882026-07-01
3 month+17.62%USD 6.812026-05-01
Year to date+52.57%USD 5.252025-12-31
1 year+22.29%USD 6.552025-07-31
3 year+21%USD 6.622023-08-01
5 year-74.37%USD 31.252021-07-30
Since inception-83.65%USD 49.002020-12-18

908 Devices Financials at a Glance

Market Cap

$328.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$57.80M

Net Income (TTM)

-$35.89M

EPS (TTM)

-$1.00

P/E Ratio

-8.02

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$7.98

Volume

335,294.548

Open

$7.56

Previous Close

$8.01

Daily Range

$7.53 - $8.01

52-Week Range

$5.03 - $9.34

Estimated Earnings Date

Aug 11, 2026

MASS: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 908 Devices

908 Devices makes handheld tools that identify unknown chemicals instantly. These devices help first responders identify dangerous illegal drugs. Portable tools provide fast laboratory results directly in the field.

Portable Tools for the Field

  • Handheld Devices: Includes the MX908 and ThreatID for identifying illicit drugs and hazardous materials; accounted for 70% of total revenue in Q1 2026.
  • Recurring Revenue: Sales of single-use swabs and service plans for the existing device base; represented 30% of total revenue in Q1 2026.
  • ZipChip Solution: Separation platform that speeds up the chemical analysis of samples during mass spectrometry.
  • AVCAD Components: Specialized parts for Aerosol and Vapor Chemical Agent Detectors sold to partners for defense applications.

Strategic Deals and Expansions

  • Sold the entire desktop bioprocessing business to Repligen Corporation in March 2025 for approximately $70 million.
  • Acquired KAF Manufacturing Company, Inc. in July 2025 to secure the internal supply of important optical parts.
  • Purchased NIRLAB SA in May 2026 to add near-infrared spectroscopy technology for instant material identification.
  • Entered a master supply agreement with an OEM Customer in June 2025 to provide precision optical assemblies over three years.

Why This Technology Stands Out

The company shrinks large laboratory mass spectrometry (Mass Spec) tools into battery-powered handheld devices for field use. Mass spectrometry is a technology that identifies materials by their chemical structure, and these portable versions give users fast answers without leaving the site.

Tracking the Quarterly Figures

  • Total revenue hit $13.4 million in Q1 2026, up 13.6% from the same period in 2025.
  • Gross profit reached $6.9 million in Q1 2026, up from $5.5 million in Q1 2025.
  • Operating cash flow reached $1.2 million in Q1 2026, an improvement from a $15 million loss in Q1 2025.
  • Net loss was $12 million in Q1 2026, worsening from a $43.6 million profit in Q1 2025 that included a gain from a business sale.

The Big Picture

908 Devices has narrowed its focus to handheld detection tools for safety and defense markets by selling its desktop business. Recent acquisitions and supply agreements show the company is moving toward controlling more of its own manufacturing and technology supply chain.

AI Generated • May 19, 2026

Industry

Electronic Equipment, Instruments and Components

Employees

172

CEO

Kevin J. Knopp, PhD

Headquarters

Burlington, MA 01803, US

MASS Financials

Key Financial Metrics (TTM)

Gross Margin

49.00%

Operating Margin

-52.50%

Net Income Margin

-62.10%

Return on Equity

-25.50%

Return on Capital

-15.07%

Return on Assets

-19.23%

Earnings Yield

-12.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$328.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

41.03M

Volume

335.29K

Avg. Volume

302.47K

Financials (TTM)

Gross Profit

$28.32M

Operating Income

-$30.35M

EBITDA

-$26.57M

Operating Cash Flow

-$7.59M

Capital Expenditure

-$836.00K

Free Cash Flow

-$8.42M

Cash & ST Invst.

$111.74M

Total Debt

$4.47M

908 Devices Performance Analysis

908 Devices annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 46,852,00011.0%
20232023-12-31USD 50,229,0007.2%
20242024-12-31USD 47,746,000-4.9%
20252025-12-31USD 56,197,00017.7%
908 Devices sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3010.7%
Q32025-09-307.4%
Q42025-12-3124.1%
Q12026-03-31-23.0%
908 Devices annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.0734.4%
20232023-12-31USD -1.135.9%
20242024-12-31USD -2.1287.7%
20252025-12-31USD -1.02-51.8%
908 Devices sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-130.1%
Q32025-09-30-10.8%
Q42025-12-31124.4%
Q12026-03-31-420.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$13.38M

+13.6%

Gross Profit

$6.38M

+15.1%

Gross Margin

47.66%

N/A

Market Cap

$328.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.91M

N/A

Employees

172

N/A

Net Income

-$11.96M

-127.4%

EBITDA

-$10.82M

-49.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$111.74M

-10.1%

Total Debt

$4.47M

+18.6%

Accounts Receivable

$9.87M

+42.4%

Inventory

$13.24M

+3.9%

Long Term Debt

$3.77M

+38.8%

Short Term Debt

$700.00K

-33.5%

Return on Assets

-19.23%

N/A

Return on Invested Capital

-20.64%

N/A

Free Cash Flow

$1.04M

+106.9%

Operating Cash Flow

$1.08M

+107.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SGHTSight Sciences, Inc.
$5.26+0.00%
CERSCerus Corporation
$2.15-25.61%
CAPRCapricor Therapeutics, Inc.
$3.85-8.11%
NPCENeuroPace, Inc.
$12.89-6.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About MASS

What is the current price of 908 Devices?

908 Devices is trading at $8.01 per share.

What is the 52-week range for 908 Devices?

Over the past 52 weeks, 908 Devices has traded between $5.03 and $9.34.

How much debt does 908 Devices have?

As of the most recent reporting period, 908 Devices reported total debt of $4.47M.

How much cash does 908 Devices have on hand?

908 Devices reported $67.56M in cash and cash equivalents in its most recent financial results.

What is 908 Devices’s dividend yield?

908 Devices does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.